| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0909178A1 Interleukin-8 as an antiviral and antitumor agent |
| 04/21/1999 | EP0717731B1 Difluoro statone antiviral analogs |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | EP0644947B1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 04/21/1999 | CN1214636A Photpheresis treatment of chronic HCV infections |
| 04/21/1999 | CN1214630A Photopheresis treatment of leukocytes |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214246A Composite antiseptic medicine |
| 04/21/1999 | CN1043043C Preparation of crystalline cephem acid addition salt |
| 04/21/1999 | CN1043042C Resolution method of alpha-(2,2-dimethylpropionyloxy) ethyl 7-[2-(2-amino-thiazol-4-yl)-2-(2)-hydroxyl-imino-acetamido]-3-(methoxy methyl)-3-cephem-4-carboxylate |
| 04/21/1999 | CA2251266A1 Beta-ketoester |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895786 Method for treating viral infections |
| 04/20/1999 | US5895655 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 04/20/1999 | US5895654 Streptococcus equi vaccine |
| 04/20/1999 | US5895651 Recombinant dengue virus envelope protein/maltose-binding protein antigens and subunit vaccine compositions containing said antigens |
| 04/20/1999 | US5895650 Prevention and treatment of retroviral disease |
| 04/20/1999 | CA2138447C Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/15/1999 | WO1999018220A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018198A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | WO1999018194A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018107A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/15/1999 | WO1999018097A1 Crystalline antifungal polymorph |
| 04/15/1999 | WO1999018083A1 N,n'-(sulphonyldi-1, 4-phenylen) bis (n'',n''- dimethylformamidin)-1, 2,3,4-tetrahydro- 6-methyl-2, 4-dioxo-5-pyrimidinsulphonate for stimulating cellular metabolism and having an immunotropic and anti-bacterial activity and method for producing the same |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999018073A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999018072A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999018071A1 Azetidinone derivatives for the treatment of hcmv infections |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017789A1 Peptide compositions for the treatment and prevention of hiv infection |
| 04/15/1999 | WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | WO1999017777A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | WO1999017773A1 Compounds and methods |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017616A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
| 04/15/1999 | WO1999006440A8 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 04/15/1999 | WO1999004774A3 Nucleotide analog compositions |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999000412A9 Interferon stimulating protein and uses thereof |
| 04/15/1999 | WO1998058668A3 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 04/15/1999 | WO1998056761A3 Benzimidazole derivatives |
| 04/15/1999 | CA2306746A1 Inhibitors of prenyl-protein transferase |
| 04/15/1999 | CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | CA2306182A1 Gene deleted recombinant felv proviral dna for production of vaccines against felv |
| 04/15/1999 | CA2305805A1 Compounds and methods |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305382A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | CA2305182A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | CA2304796A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2303954A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2273186A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0908178A1 Partial liquid breathing of fluorocarbons |
| 04/14/1999 | EP0907751A2 Dna, rna and a protein useful for detection of a mycobacterial infection |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0907633A1 New synthetic catechol derivatives, method for production and use thereof |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907373A1 Use of il-12 and ifn-alpha for the treatment of infectious diseases |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 04/14/1999 | EP0737072B1 USE OF SIMPLE AND CONJUGATED DEXTRANS in the manufacture of a medicament for PREVENTING OR REDUCING THE RISK OF INFECTION BY BACTERIAL PATHOGENS |
| 04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses |
| 04/14/1999 | CN1214051A Induction of immune responese against desired determinants |
| 04/14/1999 | CN1214049A Therapeutic compounds |
| 04/14/1999 | CN1214039A Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 04/14/1999 | CN1213979A Mask for treating cold |
| 04/14/1999 | CN1213555A Pure Chinese medicinal preparation for treating pulmonary tuberculosis |
| 04/14/1999 | CN1213539A Polygonatum sibiricum fructosans homologic mixture medicines |
| 04/14/1999 | CN1042936C Substituted aminoquinolone compound, its application and medicinal compsns. containing same |
| 04/13/1999 | US5894019 Topically applied pharmaceutical composition, method of preparing it and its use |
| 04/13/1999 | CA2159451C Unsaturated phosphonates derivatives of purines and pyrimidines |
| 04/13/1999 | CA2155129C Combinations of retroviral inhibitors |
| 04/13/1999 | CA2088732C Antimicrobial agent for staphylococcus |
| 04/13/1999 | CA2045553C Process for the preparation of vinyl ethers |
| 04/13/1999 | CA1340496C Hydroxymethyl cyclobutyl purines |